Pegylated interferon therapy during early pregnancy for hepatitis B infection: does it prevent vertical transmission?
dc.authorid | 0000-0003-1685-0352 | en_US |
dc.authorid | 0000-0003-0442-5981 | |
dc.contributor.author | Atasoy, Halil İbrahim | |
dc.contributor.author | Sırmatel, Pınar | |
dc.contributor.author | Sırmatel, Fatma | |
dc.date.accessioned | 2021-06-23T19:48:58Z | |
dc.date.available | 2021-06-23T19:48:58Z | |
dc.date.issued | 2017 | |
dc.department | BAİBÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü | en_US |
dc.description.abstract | In general, interferon (IFN) is avoided during pregnancy due to the possibility of fetal side effects. We, herein, reported two child-bearing women with chronic hepatitis B (HB) infection who used pegylated interferon alfa 2b (PEG IFN alpha 2b) in first trimester unintentionally. We compared HB contracting rates of gestations in which IFN was used and not used. The cases are unique in that they could highlight the importance of IFN use in early gestation for preventing vertical transmission particularly if combined with antiviral therapy for the rest of pregnancy. | en_US |
dc.identifier.doi | 10.1080/14767058.2016.1183639 | |
dc.identifier.endpage | 747 | en_US |
dc.identifier.issn | 1476-7058 | |
dc.identifier.issn | 1476-4954 | |
dc.identifier.issue | 6 | en_US |
dc.identifier.pmid | 27125766 | en_US |
dc.identifier.scopus | 2-s2.0-84969677189 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.startpage | 745 | en_US |
dc.identifier.uri | https://doi.org/10.1080/14767058.2016.1183639 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12491/9293 | |
dc.identifier.volume | 30 | en_US |
dc.identifier.wos | WOS:000393297500021 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.institutionauthor | Atasoy, Halil İbrahim | |
dc.institutionauthor | Sırmatel, Fatma | |
dc.language.iso | en | en_US |
dc.publisher | Taylor & Francis Ltd | en_US |
dc.relation.ispartof | Journal Of Maternal-Fetal & Neonatal Medicine | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Hepatitis B | en_US |
dc.subject | Infection | en_US |
dc.subject | Peginterferon Alfa 2b | en_US |
dc.subject | Pregnancy Outcome | en_US |
dc.title | Pegylated interferon therapy during early pregnancy for hepatitis B infection: does it prevent vertical transmission? | en_US |
dc.type | Article | en_US |
Dosyalar
Orijinal paket
1 - 1 / 1
Küçük Resim Yok
- İsim:
- halil-ibrahim-atasoy.pdf
- Boyut:
- 613.06 KB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Tam Metin/Full Text